Medexus Pharmaceuticals

Eton Pharmaceuticals

This company develops and commercialises prescription medicines to treat patients living with rare diseases.

Depomed

This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.

Mecox Curemed

This pharmaceutical company develops drug delivery systems and oncology treatments for healthcare providers and patients through platform-based drug development.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

X4 Pharmaceuticals

This biopharmaceutical company develops and commercialises oral therapies for patients with rare immune system disorders, such as WHIM syndrome and chronic neutropenia.

Mersana Therapeutics

This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.